500. Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up

Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD) in either eye who were appropriately evaluated during the initial exam and were re-evaluated no later than eight weeks.

This measure is to be submitted once per performance period for denominator eligible cases as defined in the denominator criteria. This measure is intended to reflect the quality of services provided for patients with a diagnosis of acute posterior vitreous detachment (PVD). This measure may be submitted by MIPS-eligible clinicians who perform the quality actions, as defined by the numerator, based on the services provided the measure-specific denominator coding.

Document the diabetic condition:

  1. Select a posterior vitreous detachment Diagnosis.
  2. Select a counseling PVD Plan and tap Save.
  3. Locate the counseling plan and tap Resume.
  4. Select the appropriate options from the Quality 500 drop-downs.
  5. Document the rest of the visit and Finalize.

Alternatively, code quality with a special plan:

  1. Document a Diagnosis and Plan as you normally would.
  2. Tap Special Plans and select MIPS.
  3. From Popular Plans, select MIPS Quality and tap Save.
  4. Locate the MIPS Quality plan and tap Resume.
  5. Tap the PVD tab.
  6. Select the appropriate options from the Quality 500 drop-downs.
  7. Tap Done.
  8. Document the rest of the visit and Finalize.

Eyefinity products and documentation refer to the MIPS quality numbers. Other measure numbering systems are listed here for your reference.

Quality 500
NQF —
CMS —
  • Registry
  • AAO IRIS
  • MVP

This topic describes how points are calculated for this measure. To learn more about scoring, go to Scoring.

Benchmarks are displayed here as both a chart and a table. The chart gives you a visual representation and helps you quickly compare benchmarks across different reporting methods. The table lists the specific benchmark criteria for each available reporting method.

 

Submission Method 3rd Decile 4th Decile 5th Decile 6th Decile 7th Decile 8th Decile 9th Decile 10th Decile
Registry* — — — — — — — —
AAO IRIS* — — — — — — — —
MVP* — — — — — — — —

* Benchmarking data for this submission method was unavailable at the time of publication.

Number of patients, regardless of age, who had one or more visits during the measurement period:

92002, 92004, 92012, 92014, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99242, 99243, 99244, 99245

AND a diagnosis for posterior vitreous detachment (ICD-10-CM):

H43.811, H43.812, H43.813, H43.819

AND a diagnosis for acute PVD:

M1383

A new diagnosis code, that meets the definition of acute PVD, indicates a new occurrence of PVD. If there are multiple occurrences of acute PVD, then the most recent occurrence should be utilized as denominator eligible for the purposes of submitting this measure.

Denominator Exclusions

Patients with a postoperative encounter of the eye with the acute PVD within two weeks before the initial encounter or eight weeks after initial acute PVD encounter:

M1329

OR patients with a diagnosis of acute vitreous hemorrhage:

M1328

OR encounters conducted via telehealth:

M1426

Denominator Exception

Documentation of patient reason(s) for not having a follow up exam (for example, inadequate time for follow up):

M1330

If the initial exam occurs between November 5 and December 31 of the performance period and the patient is not able to be seen for follow-up within the performance period, it would be appropriate to report the denominator exception for inadequate time for follow-up.

Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than eight weeks.

Performance Met

Patients who were appropriately evaluated during the initial exam AND were re-evaluated no later than eight weeks from initial exam

M1331

Performance Not Met

Patients who were not appropriately evaluated during the initial exam OR who were not re-evaluated within eight weeks

M1327